Search by Drug Name or NDC

    NDC 43063-0410-14 ciprofloxacin 250 mg/1 Details

    ciprofloxacin 250 mg/1

    ciprofloxacin is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is CIPROFLOXACIN HYDROCHLORIDE.

    Product Information

    NDC 43063-0410
    Product ID 43063-410_06459744-5cf8-6377-e063-6294a90ae5fd
    Associated GPIs 05000020100310
    GCN Sequence Number 009509
    GCN Sequence Number Description ciprofloxacin HCl TABLET 250 MG ORAL
    HIC3 W1Q
    HIC3 Description QUINOLONE ANTIBIOTICS
    GCN 47050
    HICL Sequence Number 004124
    HICL Sequence Number Description CIPROFLOXACIN HCL
    Brand/Generic Generic
    Proprietary Name ciprofloxacin
    Proprietary Name Suffix n/a
    Non-Proprietary Name ciprofloxacin
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 250
    Active Ingredient Units mg/1
    Substance Name CIPROFLOXACIN HYDROCHLORIDE
    Labeler Name PD-Rx Pharmaceuticals, Inc.
    Pharmaceutical Class Cytochrome P450 1A2 Inhibitors [MoA], Fluoroquinolone Antibacterial [EPC], Fluoroquinolones [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA076639
    Listing Certified Through 2024-12-31

    Package

    NDC 43063-0410-14 (43063041014)

    NDC Package Code 43063-410-14
    Billing NDC 43063041014
    Package 14 TABLET in 1 BOTTLE, PLASTIC (43063-410-14)
    Marketing Start Date 2013-02-08
    NDC Exclude Flag N
    Pricing Information N/A